APA (7th ed.) Citation

E, G., J, C., JP, C., AM, B., JM, J., J, R., . . . MJ, R. (2019). Clinical association of metabolic syndrome, C-reactive protein and testosterone levels with clinically significant prostate cancer. Journal of cellular and molecular medicine, 23(2), 934. https://doi.org/10.1111/jcmm.13994

Chicago Style (17th ed.) Citation

E, Gómez-Gómez, Carrasco-Valiente J, Campos-Hernández JP, Blanca-Pedregosa AM, Jiménez-Vacas JM, Ruiz-García J, Valero-Rosa J, Luque RM, and Requena-Tapia MJ. "Clinical Association of Metabolic Syndrome, C-reactive Protein and Testosterone Levels with Clinically Significant Prostate Cancer." Journal of Cellular and Molecular Medicine 23, no. 2 (2019): 934. https://doi.org/10.1111/jcmm.13994.

MLA (9th ed.) Citation

E, Gómez-Gómez, et al. "Clinical Association of Metabolic Syndrome, C-reactive Protein and Testosterone Levels with Clinically Significant Prostate Cancer." Journal of Cellular and Molecular Medicine, vol. 23, no. 2, 2019, p. 934, https://doi.org/10.1111/jcmm.13994.